Immunological and clinical changes in allergic asthmatics following treatment with omalizumab

International Archives of Allergy and Immunology

Volumn 131, Issue 1, 2003, Pages 46-52

  Noga, Oliver ^a   Hanf, Gerald ^a   Kunkel, Gert ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Allergic asthma; Asthma treatment; Omalizumab; rhuMAb E25

Indexed keywords

BECLOMETASONE DIPROPIONATE; HISTAMINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; OMALIZUMAB;

ADULT; AIRWAY RESISTANCE; ALLERGIC ASTHMA; ANGIONEUROTIC EDEMA; ARTICLE; BASOPHIL; BRONCHITIS; CANDIDIASIS; CELL COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; GASTROENTERITIS; HEARING IMPAIRMENT; HISTAMINE RELEASE; HUMAN; IMMUNOLOGY; INJECTION PAIN; LABORATORY TEST; MALE; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PHARYNGITIS; PRICK TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; SPIROMETRY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VERTIGO; VIRUS INFECTION;

ADULT; AIRWAY RESISTANCE; ANTIBODIES, MONOCLONAL; ASTHMA; DOUBLE-BLIND METHOD; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKINS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; SKIN TESTS; TREATMENT OUTCOME;

EID: 0038693651     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070434     Document Type: Article

References (25)

1. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225-1232.
2. Beasley R, Crane J, Lai CK, Pearce N: Prevalence and etiology of asthma. J Allergy Clin Immunol 2000;105:S466-S472.
3. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG: Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989;320:271-277.
4. Ishizaka T, Ishizaka K: Activation of mast cells for mediator release through IgE receptors. Prog Allergy 1984;34:188-235.
5. Heusser C, Jardieu P: Therapeutic potential of anti-IgE antibodies. Curr Opin Immunol 1997;9:805-813.
6. Barnes PJ: Anti-IgE antibody therapy for asthma. N Engl J Med 1999;341:2006-2008.
7. Fick RB Jr: Anti-IgE as novel therapy for the treatment of asthma. Curr Opin Pulm Med 1999;5:76-80.
8. Fahy JV, Fleming HE, Wong HH, Liu JT, Su JQ, Reimann J, Fick RB Jr, Boushey HA: The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med 1997;155:1828-1834.
9. Shields RL, Whether WR, Zioncheck K, O'Connell L, Fendly B, Presta LG, Thomas D, Saban R, Jardieu P: Inhibition of allergic reactions with antibodies to IgE. Int Arch Allergy Immunol 1995;107:308-312.
10. Milgrom H, Fick RB Jr, Su JQ, Reimann JD, Bush RK, Watrous ML, Metzger WJ: Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. N Engl J Med 1999;341:1966-1973.
11. Fox JA, Hotaling TE, Struble C, Ruppel J, Bates DJ, Schoenhoff MB: Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeys. J Pharmacol Exp Ther 1996;279:1000-1008.
12. Casale TB, Bernstein IL, Busse WW, LaForce CF, Tinkelman DG, Stoltz RR, Dockhorn RJ, Reimann J, Su JQ, Fick RB Jr, Adelman DC: Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol 1997;100:110-121.
13. Adelroth E, Rak S, Haahtela T, Aasand G, Rosenhall L, Zetterstrom O, Byrne A, Champain K, Thirlwell J, Cioppa GD, Sandstrom T: Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2000;106:253-259.
14. MacGlashan DW Jr, Bochner BS, Adelman DC, Jardieu PM, Togias A, McKenzie White J, Sterbinsky SA, Hamilton RG, Lichtenstein LM: Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:1438-1445.
15. Saini SS, MacGlashan DW Jr, Sterbinsky SA, Togias A, Adelman DC, Lichtenstein LM, Bochner BS: Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo. J Immunol 1999;162:5624-5630.
16. Boulet LP, Chapman KR, Cote J, Kalra S, Bhagat R, Swystun VA, Laviolette M, Cleland LD, Deschesnes F, Su JQ, DeVault A, Fick RB Jr, Cockcroft DW: Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med 1997;155:1835-1840.
17. Sol̀r M, Matz J, Townley R, Buhl R, O'Brien J, Fox H, Thirlwell J, Gupta N, Della Cioppa G: The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 2001;18:254-261.
18. Buhl R, Solèr M, Matz J, Townley R, O'Brien J, Noga O, Champain K, Fox H, Thirlwell J, Della Cioppa G: Omalizumab provides long-term control in patients with moderate to severe allergic asthma. Eur Respir J 2002;20:73-78.
19. Siraganian RP: Automated histamine release. A method for in vitro allergy diagnosis. Int Arch Allergy Appl Immunol 1975;49:108-110.
20. Sunyer J, Anto JM, Sabria J, Roca J, Morell F, Rodriguez Roisin R, Rodrigo MJ: Relationship between serum IgE and airway responsiveness in adults with asthma. J Allergy Clin Immunol 1995;95:699-706.
21. Haak Frendscho M, Robbins K, Lyon R, Shields R, Hooley J, Schoenhoff M, Jardieu P: Administration of an anti-IgE antibody inhibits CD23 expression and IgE production in vivo. Immunology 1994;82:306-313.
22. MacGlashan D Jr, McKenzie White J, Chichester K, Bochner BS, Davis FM, Schroeder JT, Lichtenstein LM: In vitro regulation of Fc epsilon RI alpha expression on human basophils by IgE antibody. Blood 1998;91:1633-1643.
23. Ochensberger B, Daepp GC, Rihs S, Dahinden CA: Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation. Blood 1996;88:3028-3037.
24. Wills Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD: Interleukin-13: Central mediator of allergic asthma. Science 1998;282:2258-2261.
25. Li L, Xia Y, Nguyen A, Lai YH, Feng L, Mosmann TR, Lo D: Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999;162:2477-2487.